Cynthia Appel
Psychiatric/Mental Health · Hermitage, MONPI 1932867900
Payments from drug & device makers
Across 135 payments — averaging $17.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$389
- Neurocrine Biosciences, Inc.$362
- Vanda Pharmaceuticals Inc.$351
- AbbVie$297
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$259
- Teva Pharmaceuticals USA, Inc.$95
- plus $669 from 17 others
What the payments were for
- Food & beverage$2,422100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$2,422 in reported general payments places this provider in the 70th percentile of 565 psychiatric/mental health providers in Missouri.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 34 | $290,449 |
| AustedoDeutetrabenazine | 25 | $190,788 |
| VraylarCariprazine Hcl | 70 | $94,805 |
| Invega SustennaPaliperidone Palmitate | 18 | $61,279 |
| Lurasidone Hcl | 85 | $28,743 |
| NuedextaDextromethorphan Hbr/Quinidine | 15 | $26,553 |
| Chlorpromazine Hcl | 55 | $19,642 |
| TopamaxTopiramate | 12 | $14,761 |
| TrintellixVortioxetine Hydrobromide | 30 | $14,188 |
| Aripiprazole | 198 | $8,280 |
| Divalproex Sodium ErDivalproex Sodium | 107 | $7,033 |
| Atomoxetine Hcl | 71 | $7,005 |
| Paliperidone ErPaliperidone | 56 | $6,742 |
| BelsomraSuvorexant | 14 | $6,257 |
| Carbamazepine ErCarbamazepine | 106 | $5,477 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $362 | $290,44934 claims |
| Teva Pharmaceuticals USA, Inc.Austedo | $95 | $190,78825 claims |
| AbbVieVraylar | $297 | $94,80570 claims |
| Johnson & JohnsonInvega Sustenna | $68 | $61,27918 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $63 | $26,55315 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $17 | $14,18830 claims |
| Lilly USA, LLCOlanzapine | $62 | $2,615124 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 565 psychiatric/mental health providers in Missouri.
Other psychiatric/mental health in Hermitage
- Aldijana SacicSaint Louis$510K
- Erin DuvallSpringfield$275K
- Laurel OwensLees Summit$246K
- Julie WaterburySaint Louis$135K
- Emily WoukSpringfield$90K
- Kristerpher BrimberryPoplar Bluff$74K
- Matthew LindquistSt Louis$42K
- Stacy EmersonKennett$25K
- Jeffery DavisCreve Coeur$24K
- Kelsey KingsboroughMexico$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.